Your session is about to expire
← Back to Search
5-Cog Assessment for Dementia
N/A
Recruiting
Led By Malaz Boustani, MD, MPH
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial is designed to test whether the 5-Cog assessment can help primary care doctors detect dementia in patients presenting with cognitive concerns. The study will compare the effectiveness of the 5-Cog assessment to enhanced usual care in 22 primary care clinics. Results will also be examined in NIH designated health disparity populations including underserved minority and socio-economically challenged populations.
Who is the study for?
This trial is for individuals aged 65 or older who have concerns about their memory or thinking but haven't been diagnosed with dementia. It's not open to those already diagnosed with dementia or living permanently in nursing facilities.Check my eligibility
What is being tested?
The study compares a new brief cognitive assessment called the 5-Cog Paradigm, which is quick and culturally sensitive, against enhanced usual care to see if it better detects new cases of mild cognitive impairment and dementia in primary care settings.See study design
What are the potential side effects?
Since this trial involves a non-invasive cognitive assessment tool rather than medication, there are no direct physical side effects expected from participating in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
New cognitive impairment diagnoses in the 90-day period following presentation of cognitive concern to the primary care physician (PCP).
Secondary outcome measures
Improved dementia care in the 90-day period following presentation of cognitive concern to the primary care provider (PCP).
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 5-Cog Paradigm (5-Cog battery coupled with clinical decision tool)Experimental Treatment1 Intervention
A cognitive concern screening will be conducted with patients aged 65 and older prior to their appointment with their primary care physician. If cognitive concerns are endorsed the 5-Cog battery will be conducted. The simple, <5-minute cognitive assessment will reliably identify older persons with cognitive impairment in primary care settings, and flag them for further evaluation. Depending on whether the 5-Cog results are normal or abnormal on any one of the 3 tests, appropriate clinical decision support tools are provided to the primary care physicians in electronic medical record. The primary care physicians are not instructed to follow 5-Cog suggestions verbatim but use their clinical judgment.
Group II: Enhanced usual careActive Control1 Intervention
Educational sessions for primary care physicians and clinic staff regarding cognitive detection and medical billing will be conducted. A cognitive concern screening will be conducted with patients aged 65 and older prior to their appointment with their primary care physician. The results will be provided to primary care physicians.
Find a Location
Who is running the clinical trial?
Indiana UniversityOTHER
980 Previous Clinical Trials
976,382 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,340 Previous Clinical Trials
642,764 Total Patients Enrolled
Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,850,508 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced usual care
- Group 2: 5-Cog Paradigm (5-Cog battery coupled with clinical decision tool)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are applicants being accepted for the experiment at this time?
"According to the entries on clinicaltrials.gov, this research study is no longer actively enrolling participants; it was first posted in April 15th 2023 and last edited on September 19th 2022. Notwithstanding, there are 929 other trials that one can possibly partake in at the moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger